FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liver function

[1]  M. Kurosaki,et al.  Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients , 2014, Journal of Gastroenterology.

[2]  S. Bertrais,et al.  Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C , 2014, Hepatology.

[3]  Stefan Zeuzem,et al.  Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. , 2014, The New England journal of medicine.

[4]  Sanjeev Arora,et al.  Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. , 2014, The New England journal of medicine.

[5]  E. Schiff,et al.  Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. , 2013, The New England journal of medicine.

[6]  Kenta Yamamoto,et al.  Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis. , 2013, Journal of hepatology.

[7]  H. Toyoda,et al.  Characteristics of elderly hepatitis C virus‐associated hepatocellular carcinoma patients , 2013, Journal of gastroenterology and hepatology.

[8]  Anna Persson,et al.  Preliminary study of two antiviral agents for hepatitis C genotype 1. , 2012, The New England journal of medicine.

[9]  H. Toyoda,et al.  Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan , 2011, Journal of gastroenterology and hepatology.

[10]  H. Lee,et al.  Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis. , 2010, Journal of hepatology.

[11]  A. Sanyal,et al.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  T. Umemura,et al.  Epidemiology of hepatocellular carcinoma in Japan , 2009, Journal of Gastroenterology.

[13]  William M. Lee,et al.  Efficacy and Safety of Entecavir in Patients With Chronic Hepatitis B and Advanced Hepatic Fibrosis or Cirrhosis , 2008, The American Journal of Gastroenterology.

[14]  M. Buti,et al.  Peginterferon alpha‐2b is safe and effective in HBeAg‐positive chronic hepatitis B patients with advanced fibrosis , 2007, Hepatology.

[15]  S. Pol,et al.  FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest , 2007, Hepatology.

[16]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[17]  Patrice Faure,et al.  Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. , 2007, Journal of hepatology.

[18]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[19]  Mario Plebani,et al.  Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. , 2006, Journal of hepatology.

[20]  Masatoshi Kudo,et al.  Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score , 2004, Hepatology.

[21]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[22]  A. Gatta,et al.  The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis , 2000, Hepatology.

[23]  F. Izzo,et al.  A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients , 1998, Hepatology.

[24]  R Izumi,et al.  Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. , 1994, Gastroenterology.

[25]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[26]  J. Bruix,et al.  Management of HCC. , 2012, Journal of hepatology.

[27]  Riccardo Lencioni,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.

[28]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[29]  R. Bataller,et al.  A prognostic model for predicting survival in cirrhosis with ascites. , 2001, Journal of hepatology.

[30]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.